Morningstar has valued the stock at $207 (up from $200 immediately prior to release of full year results).
They attribute approximately $57 of this $207 to the success of CSL112 (i.e. if it failed, they would removed $57 from share price valuation). They have a 50% chance of success on the CSL112 drug so I imagine if it became successful, Morningstar would add $57 to valuation.
A while ago someone posted that Goldman Sachs have a price target of $225. Does anyone have updated reports or price targets from Goldman Sachs or other brokers?
- Forums
- ASX - By Stock
- CSL
- Broker targets
Broker targets
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$308.99 |
Change
-2.340(0.75%) |
Mkt cap ! $149.9B |
Open | High | Low | Value | Volume |
$308.51 | $310.46 | $307.81 | $40.49M | 131.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16 | $308.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$309.00 | 25 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9 | 308.590 |
2 | 9 | 308.580 |
1 | 15 | 308.570 |
1 | 17 | 308.560 |
2 | 34 | 308.540 |
Price($) | Vol. | No. |
---|---|---|
308.690 | 24 | 3 |
308.700 | 40 | 5 |
308.710 | 8 | 1 |
308.720 | 25 | 1 |
308.750 | 95 | 2 |
Last trade - 12.40pm 30/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online